TO BE CONFIRMED Besins Healthcare Australia Pty Ltd
Product name
TO BE CONFIRMED
Accepted date
Sep-2025
Active ingredients
drospirenone
Summary of proposed indication
Drospirenone is proposed for the management of pelvic pain associated with endometriosis.
Application type
C (new indication)
Publication date
Sep-2025